Chief Medical Officer Paul K. Audhya sold $60K of KalVista Pharmaceuticals, Inc.

Sold$59,955

$26.78Price

2,239Shares

−1%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Tue, May 26. Filed Wed, May 27, 4:05 PM ET, after the close. Not investment advice.